ID

35254

Description

Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599); ODM derived from: https://clinicaltrials.gov/show/NCT01641666

Lien

https://clinicaltrials.gov/show/NCT01641666

Mots-clés

Versions (2)
  1. 25/02/2019 25/02/2019 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

25 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Hepatitis C NCT01641666

Anglais

Eligibility Chronic Hepatitis C NCT01641666

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
weight ≥ 40 kg to ≤ 125 kg
Description

Body Weight

Type de données

boolean

Alias
UMLS CUI [1]
C0005910
sexually active male participants and female participants of child-bearing potential must agree to use a medically acceptable form of contraception
Description

Gender Sexually active Contraceptive methods | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0241028
UMLS CUI [1,3]
C0700589
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
must have documented chronic hepatitis c genotype 1 infection
Description

Chronic Hepatitis C Genotype

Type de données

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C0017431
must have failed prior treatment with interferon plus ribavirin
Description

Prior Therapy failed | Interferon Plus Ribavirin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C3652465
UMLS CUI [2,2]
C0332287
UMLS CUI [2,3]
C0035525
must have completed treatment with interferon plus ribavirin for at least 12 weeks
Description

Treatment completed | Interferon Plus Ribavirin

Type de données

boolean

Alias
UMLS CUI [1]
C0580352
UMLS CUI [2,1]
C3652465
UMLS CUI [2,2]
C0332287
UMLS CUI [2,3]
C0035525
must have had a liver biopsy or fibroscan to determine status as cirrhotic or non-cirrhotic
Description

Status Cirrhotic Biopsy of liver | Status Non-cirrhotic Biopsy of liver | Status Cirrhotic Fibroscan | Status Non-cirrhotic Fibroscan

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449438
UMLS CUI [1,2]
C0439686
UMLS CUI [1,3]
C0193388
UMLS CUI [2,1]
C0449438
UMLS CUI [2,2]
C0439687
UMLS CUI [2,3]
C0193388
UMLS CUI [3,1]
C0449438
UMLS CUI [3,2]
C0439686
UMLS CUI [3,3]
C4522043
UMLS CUI [4,1]
C0449438
UMLS CUI [4,2]
C0439687
UMLS CUI [4,3]
C4522043
participants with cirrhosis must have had an ultrasound or imaging study within 6 months of the screening visit
Description

Liver Cirrhosis Ultrasonography | Liver Cirrhosis Imaging study

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0041618
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C1881134
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known co-infection with the human immunodeficiency virus (hiv) or the hepatitis b virus
Description

HIV Coinfection | HBV coinfection

Type de données

boolean

Alias
UMLS CUI [1]
C4505456
UMLS CUI [2]
C2242656
prior discontinuation of treatment with interferon or ribavirin due to the occurrence of an adverse event(s) considered by the investigator to be possibly or probably related to the treatment
Description

Treatment Discontinuation Due to Adverse event | Interferon | Ribavirin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0877248
UMLS CUI [2]
C3652465
UMLS CUI [3]
C0035525
treatment with ribavirin within 90 days and any interferon within 1 month of the screening visit
Description

Ribavirin | Interferon

Type de données

boolean

Alias
UMLS CUI [1]
C0035525
UMLS CUI [2]
C3652465
treatment with any investigational drug within 30 days prior to the screening visit
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
treatment with midazolam, pimozide, amiodarone, flecainide, propafenone, quinidine, or ergot derivatives within 2 weeks prior to the day 1 visit
Description

Midazolam | Pimozide | Amiodarone | Flecainide | Propafenone | Quinidine | Ergot Derivatives

Type de données

boolean

Alias
UMLS CUI [1]
C0026056
UMLS CUI [2]
C0031935
UMLS CUI [3]
C0002598
UMLS CUI [4]
C0016229
UMLS CUI [5]
C0033429
UMLS CUI [6]
C0034414
UMLS CUI [7]
C3536994
participation in any investigational trial within 30 days of the screening visit
Description

Study Subject Participation Status | Clinical Trial Investigational

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C1517586
evidence of decompensated liver disease
Description

Decompensated liver disease

Type de données

boolean

Alias
UMLS CUI [1]
C4075847
child pugh score > 6 (class b and c)
Description

Child-Pugh Classification

Type de données

boolean

Alias
UMLS CUI [1]
C2347612
diabetic and/or hypertensive participants with clinically significant ocular examination findings
Description

Study Subject Diabetic | Study Subject Hypertensive | Examination finding Ocular Clinical Significance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0241863
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0857121
UMLS CUI [3,1]
C0438105
UMLS CUI [3,2]
C1299003
UMLS CUI [3,3]
C2826293
pre-existing psychiatric conditions
Description

Mental condition Pre-existing

Type de données

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C2347662
clinical diagnosis of substance abuse
Description

Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
active or suspected malignancy
Description

Malignant Neoplasms | Malignant Neoplasms Suspected

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0750491
pregnant or nursing
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Chronic Hepatitis C NCT01641666

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Body Weight
Item
weight ≥ 40 kg to ≤ 125 kg
boolean
C0005910 (UMLS CUI [1])
Gender Sexually active Contraceptive methods | Childbearing Potential Contraceptive methods
Item
sexually active male participants and female participants of child-bearing potential must agree to use a medically acceptable form of contraception
boolean
C0079399 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Chronic Hepatitis C Genotype
Item
must have documented chronic hepatitis c genotype 1 infection
boolean
C0524910 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
Prior Therapy failed | Interferon Plus Ribavirin
Item
must have failed prior treatment with interferon plus ribavirin
boolean
C1514463 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C3652465 (UMLS CUI [2,1])
C0332287 (UMLS CUI [2,2])
C0035525 (UMLS CUI [2,3])
Treatment completed | Interferon Plus Ribavirin
Item
must have completed treatment with interferon plus ribavirin for at least 12 weeks
boolean
C0580352 (UMLS CUI [1])
C3652465 (UMLS CUI [2,1])
C0332287 (UMLS CUI [2,2])
C0035525 (UMLS CUI [2,3])
Status Cirrhotic Biopsy of liver | Status Non-cirrhotic Biopsy of liver | Status Cirrhotic Fibroscan | Status Non-cirrhotic Fibroscan
Item
must have had a liver biopsy or fibroscan to determine status as cirrhotic or non-cirrhotic
boolean
C0449438 (UMLS CUI [1,1])
C0439686 (UMLS CUI [1,2])
C0193388 (UMLS CUI [1,3])
C0449438 (UMLS CUI [2,1])
C0439687 (UMLS CUI [2,2])
C0193388 (UMLS CUI [2,3])
C0449438 (UMLS CUI [3,1])
C0439686 (UMLS CUI [3,2])
C4522043 (UMLS CUI [3,3])
C0449438 (UMLS CUI [4,1])
C0439687 (UMLS CUI [4,2])
C4522043 (UMLS CUI [4,3])
Liver Cirrhosis Ultrasonography | Liver Cirrhosis Imaging study
Item
participants with cirrhosis must have had an ultrasound or imaging study within 6 months of the screening visit
boolean
C0023890 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0023890 (UMLS CUI [2,1])
C1881134 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
HIV Coinfection | HBV coinfection
Item
known co-infection with the human immunodeficiency virus (hiv) or the hepatitis b virus
boolean
C4505456 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Treatment Discontinuation Due to Adverse event | Interferon | Ribavirin
Item
prior discontinuation of treatment with interferon or ribavirin due to the occurrence of an adverse event(s) considered by the investigator to be possibly or probably related to the treatment
boolean
C0087111 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0877248 (UMLS CUI [1,4])
C3652465 (UMLS CUI [2])
C0035525 (UMLS CUI [3])
Ribavirin | Interferon
Item
treatment with ribavirin within 90 days and any interferon within 1 month of the screening visit
boolean
C0035525 (UMLS CUI [1])
C3652465 (UMLS CUI [2])
Investigational New Drugs
Item
treatment with any investigational drug within 30 days prior to the screening visit
boolean
C0013230 (UMLS CUI [1])
Midazolam | Pimozide | Amiodarone | Flecainide | Propafenone | Quinidine | Ergot Derivatives
Item
treatment with midazolam, pimozide, amiodarone, flecainide, propafenone, quinidine, or ergot derivatives within 2 weeks prior to the day 1 visit
boolean
C0026056 (UMLS CUI [1])
C0031935 (UMLS CUI [2])
C0002598 (UMLS CUI [3])
C0016229 (UMLS CUI [4])
C0033429 (UMLS CUI [5])
C0034414 (UMLS CUI [6])
C3536994 (UMLS CUI [7])
Study Subject Participation Status | Clinical Trial Investigational
Item
participation in any investigational trial within 30 days of the screening visit
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C1517586 (UMLS CUI [2,2])
Decompensated liver disease
Item
evidence of decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Child-Pugh Classification
Item
child pugh score > 6 (class b and c)
boolean
C2347612 (UMLS CUI [1])
Study Subject Diabetic | Study Subject Hypertensive | Examination finding Ocular Clinical Significance
Item
diabetic and/or hypertensive participants with clinically significant ocular examination findings
boolean
C0681850 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0857121 (UMLS CUI [2,2])
C0438105 (UMLS CUI [3,1])
C1299003 (UMLS CUI [3,2])
C2826293 (UMLS CUI [3,3])
Mental condition Pre-existing
Item
pre-existing psychiatric conditions
boolean
C3840291 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
Substance Use Disorders
Item
clinical diagnosis of substance abuse
boolean
C0038586 (UMLS CUI [1])
Malignant Neoplasms | Malignant Neoplasms Suspected
Item
active or suspected malignancy
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial